CAS 1352608-82-2: EW-7197
Sort by
Found 6 products.
Vactosertib
CAS:Vactosertib (EW-7197) is an oral TGFBR1/ALK5 inhibitor with potential cancer-fighting properties.Formula:C22H18FN7Purity:98.85% - 99.81%Color and Shape:SolidMolecular weight:399.42Ref: TM-T6496
1g1,169.00€2mg47.00€5mg70.00€10mg96.00€25mg160.00€50mg243.00€100mg374.00€200mg552.00€500mg868.00€1mL*10mM (DMSO)77.00€N-((4-([1,2,4]Triazolo[1,5-A]Pyridin-6-Yl)-5-(6-Methylpyridin-2-Yl)-1H-Imidazol-2-Yl)Methyl)-2-Fluoroaniline
CAS:N-((4-([1,2,4]Triazolo[1,5-A]Pyridin-6-Yl)-5-(6-Methylpyridin-2-Yl)-1H-Imidazol-2-Yl)Methyl)-2-FluoroanilinePurity:98%Molecular weight:399.42g/molN-[[4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl]methyl]-2-fluoroaniline
CAS:Formula:C22H18FN7Purity:98%Color and Shape:SolidMolecular weight:399.4236232Ref: IN-DA003AC8
1g574.00€5gTo inquire10gTo inquire1mg51.00€2mg49.00€50mg157.00€100mg191.00€250mg320.00€EW 7197
CAS:Controlled ProductApplications EW-7197 is a highly potent, selective, and orally bioavailable TGF-β I receptor ALK4/ALK5 inhibitor. References Jin, C., et al.: J. Med. Chem., 57, 4213 (2014); Yoon, J., et al.: EMBO Mol. Med., 5, 1720 (2013); Son, J., et al.: Mol. Cancer Ther., 13, 1704 (2014)Formula:C22H18FN7Color and Shape:NeatMolecular weight:399.42TEW 7197
CAS:TGF-? type I receptor antagonist; anti-cancer agentFormula:C22H18FN7Purity:Min. 95%Molecular weight:399.42 g/mol
![N-((4-([1,2,4]Triazolo[1,5-A]Pyridin-6-Yl)-5-(6-Methylpyridin-2-Yl)-1H-Imidazol-2-Yl)Methyl)-2-Flu…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F54%2Fthumb%2FPC108976.jpg&w=3840&q=75)
![N-[[4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl]methyl]-2-flu…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA003AC8.jpg&w=3840&q=75)
